IP Library Granted Patent US 9,267,106
Granted Patent B2
US 9,267,106 · App. 13/368,483 · Granted Feb 23, 2016

Method for incorporation of recombinant DNA

Inventors: Mounir Izallalen (Savoy, IL); Steve Stoddard (Cerro Gordo, IL)
Assignee: Eastman Renewable Materials, LLC
C12N1/20C12N9/1007C12N9/16C12N15/74C12Y301/03016
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,267,106
App. No.
13/368,483
Granted
Feb 23, 2016
Kind
B2
Abstract

The invention provides methods of preparing bacteria of interest with a stably integrated nucleic acid sequence of interest.

Claims (28)

1. A method of providing a Clostridium sp. of interest with a stably integrated nucleic acid sequence of interest, which method comprises:

providing a dcm− bacterium containing a plasmid comprising a nucleic acid sequence of interest, wherein the nucleic acid sequence of interest comprises at least one region of identity with a genome of the bacteria of interest and a first selection marker, and wherein the dcm−bacterium and the Clostridium sp. of interest are of different species,

propagating the dcm− bacterium,

isolating the plasmid from the propagated dcm−bacteria,

transforming the Clostridium sp. of interest with the isolated plasmid to produce transformed Clostridium sp. of interest, and

culturing the transformed Clostridium sp. of interest under selective conditions and under non-selective conditions to decrease the concentration of any residual Clostridium sp. of interest that do not contain the plasmid thereby providing Clostridium sp. of interest with a stably integrated nucleic acid sequence of interest,

wherein the plasmid is self-replicating in the dcm− bacterium and the Clostridium sp. of interest.

2. The method of claim 1 , wherein the dcm− bacterium is a dcm− E. coli strain.

3. The method of claim 1 , wherein the dcm− bacterium is dam+.

4. The method of claim 1 , wherein the plasmid further comprises an origin of replication for the dcm−bacterium.

5. The method of claim 1 , wherein the at least one region of identity with the genome of the Clostridium sp. of interest is a first region of identity and a second region of identity, and wherein the first selection marker is positioned between the first and second regions of identity.

6. The method of claim 1 , wherein the Clostridium sp. of interest is Clostridium beijerinckii.

7. The method of claim 1 , wherein the plasmid further comprises an origin of replication for the Clostridium sp. of interest.

8. The method of claim 1 , wherein the first selection marker is an antibiotic resistance gene or a metabolic marker.

9. The method of claim 1 , wherein the plasmid further comprises a second selection marker.

10. The method of claim 9 , wherein the second selection marker is an antibiotic resistance gene or a metabolic marker.

11. A method of providing a Clostridium sp. with a stably integrated nucleic acid sequence of interest, which method comprises:

providing a dcm− and dam+ bacterium containing a nucleic acid molecule comprising a nucleic acid sequence of interest, wherein the nucleic acid sequence of interest comprises at least one region of identity with the genome of the Clostridium sp. and a first selection marker, and wherein the dcm− and dam+ bacterium and the Clostridium sp. are of different species,

propagating the dcm− and dam+ bacterium,

isolating the nucleic acid molecule from the propagated dcm− and dam+ bacterium, and

transforming the Clostridium sp. with the isolated nucleic acid molecule.

12. The method of claim 11 , wherein the dcm− and dam+bacterium is an E. coli strain.

13. The method of claim 11 , wherein the nucleic acid molecule further comprises an origin of replication for the dcm− and dam+ bacterium.

14. The method of claim 11 , wherein the at least one region of identity with the genome of the Clostridium sp. is a first region of identity and a second region of identity, and wherein the first selection marker is positioned between the first and second regions of identity.

15. The method of claim 11 , wherein the Clostridum sp. is Clostridium beijerinckii.

16. The method of claim 11 , wherein the nucleic acid molecule further comprises an origin of replication for the Clostridium sp.

17. The method of claim 11 , wherein the first selection marker is an antibiotic resistance gene or a metabolic marker.

18. The method of claim 11 , wherein the nucleic acid molecule further comprises a second selection marker.

Assignments (2)
CORRECTION TO NAME OF ASSIGNEE PREVIOUSLY RECORDED AT REEL 027889 AND FRAME 0655 Recorded Sep 25, 2012
From: IZALLALEN, MOUNIR; STODDARD, STEVE
To: EASTMAN RENEWABLE MATERIALS
Reel/Frame 029059/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2012
From: IZALLALEN, MOUNIR; STODDARD, STEVE
To: EASTMAN CHEMICAL COMPANY
Reel/Frame 027889/0655 →
Continuity (2)
Provisional Application 61442588 · Feb 14, 2011
Related Publication 20120208281A1 · Aug 16, 2012